Skip to main content Skip to secondary navigation

Docket #: S07-204

Size-dependent Rupture of Enveloped Viruses using Amphipathic Alpha-helical Peptides

Stanford researchers have discovered that amphipathic α-helical (AH) peptides that share an amino acid sequence homology to the N-terminus of HCV NS5A can rupture lipid vesicles in a size-dependent manner. Importantly, the range of vesicle sizes subject to rupture by the AH peptides encompasses the range of vesicle sizes of a significant number of enveloped viruses, rendering this approach useful to destroy viruses ex-vivo, e.g. for prevention and disinfection, as well as in-vivo in the infected individual.

Please see also the related technology "A Novel Process to Create Lipid Bilayer Membranes on Gold & TiO2 Solid Supports" (Stanford Docket S05-115).

Applications

  • Antiviral agent — ex-vivo and in-vivo eradication of enveloped viruses such as:
    • retroviruses
    • herpes viruses
    • flavi viruses

Advantages

  • Efficient — this invention provides for a new way to efficiently remove a large number of viruses from blood donations.
  • Broad spectrum — this invention provides for a novel type of broad-spectrum virucidal agent.

Publications

Related Links

Patents

Similar Technologies

Explore similar technologies by keyword: